Hovione and IDC Intranasal Drug Delivery Platform available for commercial partnerships
Statele Unite
From Hovione May 11 2026 Hovione, a global integrated specialist CDMO, and Industrial Design Consultancy Ltd (IDC), an international product development company, today announced that their Intranasal Drug Delivery Platform has reached a new milestone, with its lead single-use nasal dry powder device now available for commercial partnerships. Hovione and IDC have completed the device design and established initial device manufacturing and supply capability, enabling pharmaceutical partners to
din zilele anterioare